NCT02609854已完成不适用
Sustained Acoustic Medicine for Chronic Low Back Pain Secondary to Herniated Nucleus Pulposus or Other Conditions
ZetrOZ, Inc.6 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2015年11月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 65
- 试验地点
- 6
- 主要终点
- Brief Pain Inventory-Short Form (BPI-SF): Pain Severity
研究概览
简要总结
ZetrOZ's Ultrasonic Diathermy device is intended for use as a portable and wearable medical device which, when applied to various areas of the body applies Low Intensity Therapeutic Ultrasound (LITUS) to deep tissues. This device is FDA-cleared for pain reduction, treatment of muscle spasm and joint contracture, and increasing local circulation. This study will look at the use of therapeutic ultrasound to relieve pain and reduce disability in subjects with chronic low back pain, a subset of which will have chronic low back pain due to a herniated disc, over an 8-week treatment period.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of Chronic low back pain, may be secondary to herniated nucleus pulposus (HNP) or other causes
- •18-60 years of age, inclusive
- •Has Numeric Rating Scale (NRS) pain severity score of at least 4 for a minimum 5 days over the 1 week Baseline Period prior to being randomized to treatment
- •Pain lasting >3 months
- •Has MRI from within 2 months prior to Screening (If no recent MRI is available, then subject must agree to have MRI performed prior to randomization of treatment)
- •If pain is secondary to HNP: MRI within the last 2 months demonstrating the presence of a herniated disc; herniated disc is laterally located and not centrally located; herniated disc is not sequestered
- •Has the presence of radicular pain as assessed by a health care practitioner
- •Is willing and able to self-administer treatment daily within their place of residence or during normal daily activity, excluding bathing, showering, or other water activities which may result in submersion of the study device.
- •Is maintained on a stable pain management regimen, which may include opioid and/or non-opioid analgesic medications, but must be willing to keep dosage(s) stable through the study period; any dose adjustments that the investigator feels are required during the study period must be discussed with the study sponsor; and the use of any medications must be documented in the subject's Medication Log.
- •Be willing to discontinue any other interventional treatment modalities on the lower back during the study period (e.g., transcutaneous electrical nerve stimulation, electronic muscle stimulation, traditional ultrasound).
排除标准
- •Cannot successfully demonstrate the ability to put on and take off the device.
- •Displays any condition which, in the judgment of the investigator, would make participation in the study unacceptable including, but not limited to, the subject's ability to understand and follow instructions.
- •Participated in a clinical trial for an investigational drug and/or agent within 30 days prior to screening.
- •Has arthritis, bone spurs, stenosis, fusions, or implants near the treatment area.
- •Is pregnant.
- •Is a prisoner.
- •Is non-ambulatory (unable to walk).
- •Has a pacemaker.
- •Has a malignancy in the treatment area.
- •Has an active infection, open sores, or wounds in the treatment area.
- •Has impaired sensation in the treatment area, such as caused by chemotherapy or anesthesia.
- •Has a known neuropathy (disease of the brain or spinal nerves).
- •Has a hereditary disposition (tendency) for excessive bleeding (hemorrhage).
- •Has peripheral artery disease.
- •Has BMI ≥30
结局指标
主要结局
Brief Pain Inventory-Short Form (BPI-SF): Pain Severity
时间窗: Change from Baseline to Week 8
次要结局
- Oswestry Disability Index(Change from Baseline to Week 8)
- Numeric Rating Scale: Pain on Flexion(Change from Baseline to Week 8)
- BPI-SF: Pain Interference(Change from Baseline to Week 8)
- Numeric Rating Scale: Pain on Extension(Change from Baseline to Week 8)
研究者
研究点 (6)
Loading locations...
相似试验
已完成
不适用
Long Duration Therapeutic Ultrasound for Tendon HealingTendinosisTendinitisTendinopathyNCT02466308ZetrOZ, Inc.28
已完成
不适用
Wearable LITUS Device for Osteoarthritis of the Knee: a Randomized Double-Blind Placebo-Controlled TrialKnee OsteoarthritisNCT02083861ZetrOZ, Inc.93
已完成
2 期
Sustained Acoustic Medicine for Symptomatic Treatment of Knee Pain Related to OsteoarthritisOsteo Arthritis KneeArthritisNCT06257537ZetrOZ, Inc.307
招募中
不适用
Low-Energy Ultrasound, Electrical and Magnetic Field Stimulation in Therapy-Resistant Myofascial Pain SyndromeMyofascial Pain Syndrome - Lower BackMyofascial Pain Syndrome - NeckMyofascial Pain Syndrome - Tension HeadacheNCT05851326Sobet AG126
招募中
1 期
Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to Bone FractureBone FractureFresh FractureNCT05883241ZetrOZ, Inc.90